“In the absence of any substantive conflicts across the four pillars—but with only the machine pillar populated—we assign a cautious, provisional posture. The technology shows clear promise for improving spatial transcriptomics accuracy, yet persistent coverage gaps, high cost, and implementation complexity introduce moderate-to-high uncertainty. Without corroborating insights from mapping, cellular/molecular mood, and mechanistic studies, the overall risk remains elevated due to incomplete evidence.”